Statement on conjugate meningococcal vaccine for serogroups   A, C, Y and W135. An Advisory Committee Statement (ACS).
D000293:Adolescent; D000328:Adult; D000368:Aged; D002170:Canada / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D006801:Humans; D015994:Incidence; D007223:Infant; D008585:Meningitis, Meningococcal / Q000453:epidemiology / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D008875:Middle Aged; D018074:Vaccines, Conjugate / Q000009:adverse effects / Q000627:therapeutic use
D022401:Meningococcal Vaccines; D018074:Vaccines, Conjugate